youtube_live
Q3 2026 earnings • released • EPS miss -1.81% • Revenue beat +3.41%
See resultschevron_right
1SXP:ETR
SCHOTT Pharma AG & Co KgaA
€21.95
arrow_upward
+0.69%(+0.15) 1D
Aug 14, 5:35:12 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1SXP...
Open
€22.05
High
€22.40
Low
€21.75
Mkt. cap
3.30B
Avg. vol.
76.25K
Volume
54.01K
Dividend
0.82%
Quarterly dividend
€0.05
Ex-dividend date
Feb 4, 2026
P/E ratio
23.05
52-wk high
€24.10
52-wk low
€12.62
EPS
€0.95
Shares outstanding
150.61M
No. of employees
5K
Open
€22.05
High
€22.40
Low
€21.75
Mkt. cap
3.30B
Avg. vol.
76.25K
Volume
54.01K
Dividend
0.82%
Quarterly dividend
€0.05
Ex-dividend date
Feb 4, 2026
P/E ratio
23.05
52-wk high
€24.10
52-wk low
€12.62
EPS
€0.95
Shares outstanding
150.61M
No. of employees
5K
News stories
From web sources and news partners
Simply Wall Street
·
14 hours ago
SCHOTT Pharma AG & Co. KGaA (ETR:1SXP) Just Reported And Analysts Have Been Lifting Their Price Targets
Profile
Schott Pharma is a provider of drug containment solutions and delivery systems for injectable drugs. Originally a division of glass manufacturer Schott AG, the company went public on the Frankfurt Stock Exchange in 2023. Headquartered in Mainz, Germany, the company operates in 14 countries. Wikipedia
About SCHOTT Pharma AG & Co KgaA
AI content may include mistakes. Learn more